Literature DB >> 24894815

Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.

S P O Jansson1, K Svärdsudd, D K G Andersson.   

Abstract

AIMS: To analyse the effects of hyperglycaemia and hypertension and treatment of diabetes and hypertension on cardiovascular disease incidence in patients with Type 2 diabetes with up to 30 years of follow-up.
METHODS: A total of 740 patients with incident Type 2 diabetes were registered at the Laxå Primary Health Care Centre, Sweden between 1972 and 2001. Annual data on mean fasting blood glucose, systolic, diastolic and mean arterial blood pressure, and type of diabetes and hypertension treatment were obtained from patient records, and information on cardiovascular disease, myocardial infarction and stroke events was obtained from national registers.
RESULTS: During the follow-up period, cumulative cardiovascular disease incidence increased significantly with male sex (hazard ratio 1.48, 95% CI 1.21-1.82), number of previous cardiovascular disease events (hazard ratio 1.13, 95% CI 1.08-1.18), age, per year (HR 1.05, 95% CI 1.04-1.07), mean fasting blood glucose, per mmol/l (hazard ratio 1.05, 95% CI 1.00-1.10) BMI (hazard ratio 1.04, 95% CI 1.01-1.06), mean arterial blood pressure, per mmHg (hazard ratio 1.02, 95% CI 1.01-1.03), and decreased significantly with metformin treatment (hazard ratio 0.58, 95% CI 0.38-0.90) and sulfonylurea (hazard ratio 0.73, 95% CI 0.55-0.97). Cumulative myocardial infarction incidence increased significantly with male sex, number of previous myocardial infarction events, mean fasting blood glucose level, BMI, age and mean arterial blood pressure, and decreased with metformin treatment. Cumulative stroke incidence increased with number of previous stroke events, age and mean arterial blood pressure.
CONCLUSIONS: The cumulative incidence of cardiovascular disease and myocardial infarction increased with number of previous events and presence of hyperglycaemia and hypertension and decreased with pharmacological treatment of diabetes. A higher number of previous stroke events increased the cumulative incidence of stroke but no protective effect of pharmacological treatment was observed.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894815     DOI: 10.1111/dme.12514

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

Review 1.  Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes.

Authors:  M Carolina Archundia Herrera; Fatheema B Subhan; Catherine B Chan
Journal:  Curr Obes Rep       Date:  2017-12

2.  Prevalence and Determinants of Hypertension Among Diabetic Patients in Jimma University Medical Center, Southwest Ethiopia, 2019.

Authors:  Daba Abdissa; Kumsa Kene
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-01       Impact factor: 3.168

3.  Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial.

Authors:  Kuat Oshakbayev; Bibazhar Dukenbayeva; Gulnar Togizbayeva; Aigul Durmanova; Meruyert Gazaliyeva; Abdul Sabir; Aliya Issa; Alisher Idrisov
Journal:  Nutr Metab (Lond)       Date:  2017-01-31       Impact factor: 4.169

4.  Blood pressure control and its determinants among diabetes mellitus co-morbid hypertensive patients at Jimma University medical center, South West Ethiopia.

Authors:  Sintayehu Muleta; Tsegaye Melaku; Legese Chelkeba; Desta Assefa
Journal:  Clin Hypertens       Date:  2017-12-27

Review 5.  The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review.

Authors:  Omorogieva Ojo
Journal:  Int J Environ Res Public Health       Date:  2016-09-23       Impact factor: 3.390

6.  Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?

Authors:  S W Chang; Y Gong; C W McDonough; T Y Langaee; N Nasiri Kenari; A L Beitelshees; J G Gums; A B Chapman; S T Turner; J A Johnson; R M Cooper-DeHoff
Journal:  Clin Transl Sci       Date:  2016-03-07       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.